发明名称 Substituted 9,11-dioxo-2,3,4a,5,9,11,13,13a-octahydor-1H-pyrido[1,2-a]pyrrolo[1′,2′:3,4]imidazo[1,2-d]pyrazines
摘要 The present invention is directed to a process for the preparation of a compound of formula 1b which compound is useful as a prodrug of HIV integrase inhibitors and therefore is useful in the inhibition of HIV replication, the prevention and/or treatment of infection by HIV, and in the treatment of AIDS and/or ARC. The process includes the steps of a) brominating a compound of formula P-7 to form a compound of formula P-8, b) treating a compound of formula P-8 with NaIO4 to form a compound of formula P-9, c) reacting a compound of formula P-9 with [(2R)-pyrrolidinylmethyl]amine of formula to form a compound of formula P-10, d) reacting a compound of formula P-10 with 2, 4-difluorobenzylamine to form a compound of formula P-11, e) treating a compound of P-11 with palladium on carbon and ammonium hydroxide to form a compound of formula 1a, and f) treating a compound of formula 1a with NaOH and ethanol to form a compound of formula 1b. The structures of the above mentioned compounds are disclosed in the specification.
申请公布号 US8183372(B2) 申请公布日期 2012.05.22
申请号 US200913055046 申请日期 2009.07.23
申请人 JOHNS BRIAN ALVIN;AOYAMA YASUNORI;YOSHIDA HIROSHI;TAODA YOSHIYUKI;SHIONOGI & CO., LTD.;GLAXOSMITHKLINE LLC 发明人 JOHNS BRIAN ALVIN;AOYAMA YASUNORI;YOSHIDA HIROSHI;TAODA YOSHIYUKI
分类号 C07D241/36 主分类号 C07D241/36
代理机构 代理人
主权项
地址